IL28B genotype and the expression of ISGs in normal liver

IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease

(2012) Salvatore Petta et al.   JOURNAL OF HEPATOLOGY

Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance

(2011) Julia di Iulio et al.   HEPATOLOGY

A diverse range of gene products are effectors of the type I interferon antiviral response

(2011) John W. Schoggins et al.   NATURE

Hepatitis C Virus Protects Human B Lymphocytes from Fas-Mediated Apoptosis via E2-CD81 Engagement

(2011) Zhihui Chen et al.   PLoS One

Interferon-lambda and therapy for chronic hepatitis C virus infection

(2011) Raymond P. Donnelly et al.   TRENDS IN IMMUNOLOGY

ISG15 and immune diseases

(2010) Young Joo Jeon et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

An IL28B Polymorphism Determines Treatment Response of Hepatitis C Virus Genotype 2 or 3 Patients Who Do Not Achieve a Rapid Virologic Response

(2010) Alessandra Mangia et al.   GASTROENTEROLOGY

A Polymorphism Near IL28B Is Associated With Spontaneous Clearance of Acute Hepatitis C Virus and Jaundice

(2010) Hans L. Tillmann et al.   GASTROENTEROLOGY

Hepatic ISG Expression Is Associated With Genetic Variation in Interleukin 28B and the Outcome of IFN Therapy for Chronic Hepatitis C

(2010) Masao Honda et al.   GASTROENTEROLOGY

Interferon-Induced Gene Expression Is a Stronger Predictor of Treatment Response Than IL28B Genotype in Patients With Hepatitis C

(2010) Michael T. Dill et al.   GASTROENTEROLOGY

Co-stimulatory molecule CD80 expression may correlate with anti-HCV treatment outcome

(2010) A. Sacchi et al.   GUT

IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C

(2010) Thomas J. Urban et al.   HEPATOLOGY

Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection

(2010) Andrew J. Muir et al.   HEPATOLOGY

Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients

(2010) Christoph Sarrazin et al.   JOURNAL OF HEPATOLOGY

IL28B inhibits hepatitis C virus replication through the JAK–STAT pathway

(2010) Leiliang Zhang et al.   JOURNAL OF HEPATOLOGY

Peripheral Blood B Cell Subset Skewing Is Associated with Altered Cell Cycling and Intrinsic Resistance to Apoptosis and Reflects a State of Immune Activation in Chronic Hepatitis C Virus Infection

(2010) J. M. Sugalski et al.   JOURNAL OF IMMUNOLOGY

Preclinical and Clinical Development of Pegylated Interferon-Lambda 1 in Chronic Hepatitis C

(2010) Eleanor L. Ramos   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Peripheral blood memory B cells are resistant to apoptosis in chronic hepatitis C patients

(2010) Toshiaki Mizuochi et al.   VIRUS RESEARCH

Enhanced RIG-I expression is mediated by interferon regulatory factor-2 in peripheral blood B cells from hepatitis C virus-infected patients

(2009) Atsuko Masumi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Types I and II interferons upregulate the costimulatory CD80 molecule in monocytes via interferon regulatory factor-1

(2009) B. Bauvois et al.   BIOCHEMICAL PHARMACOLOGY

Expression of TIP30 Tumor Suppressor Gene Is Down-Regulated in Human Colorectal Carcinoma

(2009) Xiaobing Chen et al.   DIGESTIVE DISEASES AND SCIENCES

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

(2009) Dongliang Ge et al.   NATURE

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

(2009) David L. Thomas et al.   NATURE

IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

(2009) Vijayaprakash Suppiah et al.   NATURE GENETICS

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

(2009) Yasuhito Tanaka et al.   NATURE GENETICS

A fresh look at interferon-α signaling and treatment outcomes in chronic hepatitis C

(2008) Pantxika Bellecave et al.   HEPATOLOGY

Serum 90K/Mac-2 Binding Protein (Mac-2BP) as a Response Predictor to Peginterferon and Ribavirin Combined Treatment in Hcv Chronic Patients

(2008) Palma A. Iacovazzi et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Interferon signaling and treatment outcome in chronic hepatitis C

(2008) M. Sarasin-Filipowicz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA